Velan-Repertoire to Withdraw Director Nominations Due to Pending Sale of Radius Health

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Tags

07/11/2022 - 08:00 AM

Sale Announcement Follows Successful Velan-Repertoire Campaign Featuring Three World-Class Director Candidates

ALPHARETTA, Ga.--(BUSINESS WIRE)-- Velan Capital Investment Management LP and Repertoire Partners LP (together with the other participants in their solicitation, “Velan-Repertoire” or “we”), collectively one of the largest stockholders of Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS), with beneficial ownership of approximately 7.7% of the outstanding shares and economic exposure to approximately 10.1% of the outstanding shares, today released the following statement:

“While we believe that the proposed sale to Gurnet Point Capital and Patient Square Capital does not reflect the full price of the Company and its assets, we are pleased that our involvement drove an outcome that ultimately should allow stockholders to recoup a portion of the value that has been lost under Radius’ current Board of Directors.

As a result, we are withdrawing our director nominations. We are grateful to our exceptionally qualified director candidates Eric Ende, Cynthia Flowers, and Ann MacDougall for their time, expertise, and dedication to improving the Radius Board of Directors. We would also like to thank the fellow stockholders who supported us and our nominees both privately and publicly.”